Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
  • Advertisement

    Cancer

    July

    The cheap vegetable that could save your life

    According to a new study, eating carrots increases carotenoids in your skin. These phytonutrients lead to a lower risk of chronic disease and a stronger immune function.

    • Jack Rear

    June

    Humans typically struggle to see patterns in complex high-frequency transactions, but computers can be trained to identify networks and suspicious transactions.

    Why people with cancer don’t get the full benefit of clinical trials

    Australian researchers say regulators should mandate the requirement to share data.

    • Jill Margo
    Telix chief executive Christian Behrenbruch had hoped to tap deeper pools of capital in the US.

    Telix pulls $300m Nasdaq IPO as investors demand deep discount

    The cancer treatment hopeful had announced plans to list in New York only last week as it searched for more capital. On Friday, it withdrew from the initial public offering.

    • Kylar Loussikian
    Dan Collins founded GenesisCare in Brisbane.

    GenesisCare’s valuation shrinks to less than $500m after bankruptcy

    Once a global cancer services giant, the company’s new owners are buying back shares from local backers for just $0.000186 as the business is restructured.

    • Carrie LaFrenz
    Immutep chief executive Marc Voigt says there is a pathway to approval for the company’s lung cancer treatment by 2027.

    Immutep raises $100m and signs with Merck on ‘blockbuster’ drug

    Shares in the oncology therapy hopeful have risen some 45 per cent in the last 12 months as the company nears the commercialisation of its drug, Efti.

    • Kylar Loussikian
    Advertisement
    Listed immunotherapy drug company Immutep was on the hunt for fresh equity on Monday.

    Biotech Immutep seeks $102 million, taps three brokers

    The offer price reflects a 15.6 per cent discount to the last close.

    • Sarah Thompson, Kanika Sood and Emma Rapaport

    May

    Former health minister Greg Hunt at a ceremony for victims of thalidomide poisoning in Parliament House last November.

    Former Liberal health minister appointed to cancer biotech’s board

    Greg Hunt’s new company is developing a cure for a form of myeloma, a rare disease that begins in bone marrow.

    • Aaron Patrick
    “About 80 per cent of women discover they are at average risk, which can be reassuring in itself,” says Kelly-Anne Phillips.

    How women can reduce the risk of breast cancer by 50pc

    The science is sound but is not widely known that many women at increased risk of breast cancer can halve the risk with “anti-hormone” drugs.

    • Jill Margo
    An MRI scan. A trial showed that twice as many cases of prostate cancer were picked up by such scans than by the diagnostic blood tests in use at the moment.

    The nine things every man needs to know about prostate cancer now

    Experts at the cutting edge of new research into the causes and treatments answer the questions you might be afraid to ask.

    • Catalina Stogdon

    April

    OpenAI’s model all but matches doctors in assessing eye problems

    Ophthalmology has been a big focus of efforts to put AI to clinical use and fix obstacles to take-up, such as the tendency of models to ‘hallucinate’ by creating fictitious data.

    • Michael Peel
    Volpara Health Technologies CEO Dr Ralph Highnam wants to help detect breast cancer earlier. 

    Volpara Health takeover set to sail through shareholder vote

    South Korean suitor Lunit moved to acquire the breast cancer detection medtech last year, entering into a scheme of arrangement with the board in December.

    • Sarah Thompson, Kanika Sood and Emma Rapaport
    written by Ben Groundwater
iStock image for Traveller. Re-use permitted.

    Revolutionary app offers vital prostate cancer info

    A new online web app put out by the Prostate Cancer Foundation of Australia aims to help those living, recovering and at risk of the disease.

    • Sophia McCaughan

    March

    Bowel cancer is a common form of cancer in Australia and is becoming more prevalent in younger people.

    Multivitamins can help survival from bowel cancer

    A study examining the dose-related influence of multivitamins on non-metastatic colorectal cancer is believed to be the first of its kind.

    • Jill Margo
    There’s a startling rise in gum disease among the young.

    The five factors behind rising rates of cancer in under 40s

    Global cases in the under 50s are also rising rapidly, increasing by 79 per cent between 1990 and 2019 according to recent research.

    • David Cox

    Princess Catherine and the power of a cancer diagnosis

    This year began as an annus horribilis for the royal family, but compassion coupled with a respectful fear of cancer, changed the narrative.

    • Jill Margo
    Advertisement
    It is not known how long Princess Kate’s chemotherapy will continue, nor how long it will take her to recover from its side effects and return to public life.

    What Princess Kate’s ‘preventative chemotherapy’ means

    With metastatic cancer, chemotherapy is used to make people more comfortable. With earlier stages of cancer, like Princess Kate’s, it aims to increase the chances of cure.

    • Updated
    • Jill Margo
    A new study suggests the first ice-free day in the Arctic is likely to occur within 10 years.

    Research we’re watching: pancreatic cancer, dementia, Arctic ice

    We look at recent research in: pancreatic cancer; three-dimensional processors; an ice-free Arctic; a dementia breakthrough; and a new cash crop for Australia.

    • Alana Piper

    February

    There are differences in risk as you age.

    How the risk of cancer changes with age

    The type of cancers that affect us in old age tend to strike different organs and have very different underlying causes, compared with the ones that strike people in their youth.

    • David Cox
    GenesisCare is the largest operator of cancer care clinics in the country.

    GenesisCare emerges from bankruptcy, cuts deal with government

    The country’s largest cancer treatment group had charged patients for treatment when it was required by the federal government to only bulk bill them.

    • Carrie LaFrenz and Jemima Whyte
    Ruth Limkin faced a myriad of questions when diagnosed with breast cancer in 2019.

    How these company bosses handled their cancer diagnoses

    These bosses know all too well what King Charles is going through, having been given their own confronting news.

    • Sally Patten